Details

Autor(en) / Beteiligte

• Lin, Guo-Wen
• Yao, Xu-Dong
• Ye, Ding-Wei
• Zhang, Shi-Lin
• Dai, Bo
• Zhang, Hai-Liang
• Ma, Chun-Guang

Titel

ADAM9 decreases in castration resistant prostate cancer and is a prognostic factor for overall survival

Ist Teil von

• Chinese medical journal, 2012-11, Vol.125 (21), p.3800-3805

Ort / Verlag

China: Department of Oncology, Shanghai Medical College of Fudan University, Shanghai 200032, China

Erscheinungsjahr

2012

Quelle

MEDLINE

Beschreibungen/Notizen

• Background A disintegrin and metalloprotease 9 （ADAM9） is a membrane-anchored enzyme which is considered to be involved in some diseases including tumor. However, the role of ADAM9 in castration resistant prostate cancer （CRPC） is not clear. This study aimed to explore the different expressions on protein and messenger RNA （mRNA） level of ADAM9 between hormonal sensitive prostate cancer （HSPC） and CRPC tissue, and find the correlation with prognosis.